| scholarly article | Q13442814 |
| P50 | author | Dean Burkin | Q56759871 |
| P2093 | author name string | Jianming Liu | |
| Stephen J Kaufman | |||
| Praveen B Gurpur | |||
| P2860 | cites work | Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy | Q24310537 |
| Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle | Q24538577 | ||
| Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo | Q28206290 | ||
| Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases | Q28250493 | ||
| Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells | Q28366303 | ||
| Role for the alpha7beta1 integrin in vascular development and integrity | Q28504523 | ||
| A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification | Q28574258 | ||
| Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 | ||
| The alpha7beta1 integrin in muscle development and disease | Q33592124 | ||
| Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21 | Q33966727 | ||
| Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. | Q34065460 | ||
| Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice | Q35083511 | ||
| Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro | Q36209334 | ||
| Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice | Q36324105 | ||
| Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice | Q36381102 | ||
| Signaling pathways in skeletal muscle remodeling | Q36498310 | ||
| Increasing alpha 7 beta 1-integrin promotes muscle cell proliferation, adhesion, and resistance to apoptosis without changing gene expression | Q36995702 | ||
| Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy | Q37073808 | ||
| Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. | Q39674949 | ||
| Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells | Q40346712 | ||
| Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse | Q40849017 | ||
| Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. | Q40915594 | ||
| Mechanism of activation and function of protein kinase B. | Q41732739 | ||
| Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin | Q42829173 | ||
| Alpha7beta1-integrin regulates mechanotransduction and prevents skeletal muscle injury | Q46900053 | ||
| Valproic acid: metabolite concentrations in plasma and brain, anticonvulsant activity, and effects on GABA metabolism during subacute treatment in mice. | Q48950581 | ||
| Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles | Q72427669 | ||
| Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy | Q73677664 | ||
| T-cell-dependent fibrosis in the mdx dystrophic mouse | Q73952718 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| P304 | page(s) | 999-1008 | |
| P577 | publication date | 2009-01-29 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy | |
| P478 | volume | 174 |
| Q37610585 | "Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders |
| Q35853255 | A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90. |
| Q42639922 | Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy |
| Q53378646 | Antifibrogenic role of valproic acid in streptozotocin induced diabetic rat penis. |
| Q35057217 | Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice |
| Q37944530 | Cell-matrix interactions in muscle disease |
| Q37613392 | Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis |
| Q60917438 | Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero |
| Q28472268 | Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening |
| Q35100070 | Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling |
| Q37137768 | Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy |
| Q84847497 | Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle |
| Q36179105 | Molecular and cellular mechanisms of skeletal muscle atrophy: an update. |
| Q21296867 | Molecular and therapeutic potential and toxicity of valproic acid |
| Q35011121 | Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate |
| Q26769962 | Oxidative Stress-Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and Therapies |
| Q33659344 | PI3K/AKT/mTOR Signaling Mediates Valproic Acid-Induced Neuronal Differentiation of Neural Stem Cells through Epigenetic Modifications |
| Q92489474 | Recent advances in Duchenne muscular dystrophy |
| Q45781418 | Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy |
| Q58805825 | Secreted Frizzled-Related Protein-2 Inhibits Doxorubicin-Induced Apoptosis Mediated through the Akt-mTOR Pathway in Soleus Muscle |
| Q40133127 | Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro. |
| Q35664342 | Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia |
| Q33634392 | Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways |
| Q34106342 | The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy |
| Q33583992 | The neurotrophic and neuroprotective effects of psychotropic agents. |
| Q33707964 | Therapeutic targeting of signaling pathways in muscular dystrophy |
| Q90263455 | Valproic Acid Enhances Reprogramming Efficiency and Neuronal Differentiation on Small Molecules Staged-Induction Neural Stem Cells: Suggested Role of mTOR Signaling |
| Q28484912 | Valproic acid induces cutaneous wound healing in vivo and enhances keratinocyte motility |
| Q57040047 | Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophy |
| Q36717858 | Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis |
Search more.